17 Sep 2025 | 5 Mins Read
Gland Pharma shares decline 2.02% amidst Nifty Midcap 150 losers
Flipitmoney
Shares of Gland Pharma declined 2.02% to Rs 1,981 on Wednesday. Gland Pharma's consolidated revenue for June 2025 was Rs 1,505.62 Crore, up 5.57% from Rs 1,424.91 Crore in March 2025, with a net profit of Rs 215.48 Crore, compared to Rs 186.54 Crore in the previous quarter. The company's consolidated revenue for the year-ending March 2025 was Rs 5,616.50 Crore, with a net profit of Rs 698.53 Cr.